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CORRESPONDENCE
Patients with high CAC burden and advanced COPD GOLD stage had ≈3-fold higher risk of all-cause mortality. In comparison with other cohorts without lung disease, the prediction of CAC on all-cause mortality is quite comparable, 5 suggesting no attenuation or competing risk from COPD. Considering that CVD is a more frequent cause of morbidity and mortality in this vulnerable population, there is a need to increase the awareness among persons with COPD that there is an underlying risk for clinical and subclinical CVD. Almost half of this cohort of smokers had no detectable CAC on ungated lung CT scans. The clinical importance of this study is the predictive power for mortality of CAC on routine CT scans, and the potential to screen for CVD among the 19 million ungated thoracic scans done annually in the United States, without additional radiation, cost, or participant burden.
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